Back

Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (3) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Saket Ramraika

Lucknow (India)

6 More presentations in this session

Presentation thumbnail
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
The effect of baseline prediabetes on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.
Doctor J. Sangha (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Lipoprotein-(a) and mitral annular calcification: a systematic review and meta-analysis
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Longitudinal impact of lipid levels on subclinical atherosclerosis in adolescents: insights from the LOOK study
Doctor C. Abhayaratna (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
The determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein(a). The results from the STAR-Lp(a) study.
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Efficacy of combination lipid lowering therapy in achieving low density lipoprotein cholesterol targets after one month of event in patients with acute coronary syndrome
thumbnail
Congress Presentation
Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India
thumbnail
Congress Presentation
Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources